Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014.
Europe keeps announcing deals aimed at replacing US tech, payments, military equipment. I imagine losing a fairly rich market with twice the population of the US might cause some growth projections to be corrected way down.
Is this winning?
As a software consultant that recently spent a year removing fiserv from a client's tech stack, their product is complete ass and the only reason they have any customers at all is because it's very expensive to remove them. This is not a company whose growth prospects I would be investing in.
My usa deleveraging plan: vxus, gold miners and for tech upside higher than any mag 7 go sk hynix+tsmc+asml. Add some EM with china, india, latin america exposure and should be perfect. Possibly rklb cause why not. Gonna crush spy.